Sivextro FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved June 20, 2014)
Brand name: Sivextro
Generic name: tedizolid phosphate
Dosage form: Tablets and Injection
Company: Merck
Treatment for: Skin and Structure Infection
Sivextro (tedizolid phosphate) is an oxazolidinone antibiotic drug indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Development timeline for Sivextro
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.